IMMU-30. UTILIZING A NOVEL MASS CYTOMETRY-BASED IMMUNOMONITORING PLATFORM FOR THE CHARACTERIZATION OF VACCINE-REACTIVE, EPITOPE-SPECIFIC CD8(+) T-CELLS IN HLA-A*0201(+) PATIENTS WITH K27M(+) DIFFUSE MIDLINE GLIOMAS

Diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG) constitutes up to 20% of pediatric brain cancer and has a median survival of less than one year. We have identified a novel HLA-A*02:01-restricted neoantigen epitope encompassing the H3.3K27M mutation and implemented a p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Taitt, Jared, Watchmaker, Payal, Nejo, Takahide, Almeida, Neil, Okada, Kaori, Shahin, Maryam, Gilbert, Ryan, Mueller, Sabine, Okada, Hideho
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846708/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.522
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares